RSS   Newsletter   Contact   Advertise with us
Post Online Media

Aerie Pharmaceuticals appoints chief commercial officer

Aerie PharmaceuticalsAerie Pharmaceuticals, a clinical-stage pharmaceutical company, announced the appointment of Judith J. Robertson as chief commercial officer.

Ms. Robertson will be responsible for leading the global commercialization of Aerie’s ophthalmology franchise.

READ MORE Aerie Pharmaceuticals elects new board member

Ms. Robertson joins Aerie from the Janssen Pharmaceutical Companies of Johnson & Johnson, where she has been the VP of Global Immunology, Ophthalmology and Global Analytics since 2013.

Prior to Janssen, Ms. Robertson was VP of Global Ophthalmology at Alcon, VP of Global Respiratory at Novartis, and President of Bristol Myers Squibb Canada.


 LATEST MOVES FROM California 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy